Health and Healthcare

Mylan Inc. : MYL

All MYL Articles

180 Articles

Chris Lange | May 6, 2019 at 11:05 AM EDT

What to Expect When Mylan Reports Tuesday

Mylan is scheduled to release its first-quarter financial results before the markets open on Tuesday, and earnings are expected to…

Chris Lange | May 5, 2019 at 10:25 AM EDT

Lyft, GoPro, Disney, Yelp and More Major Earnings Coming This Week

24/7 Wall St. has put together a preview of the most prominent earnings reports expected this week, including Disney, Lyft…

Jon C. Ogg | Mar 20, 2019 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan, NextEra, Peabody, Teva, Yum Brands and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan,…

Jon C. Ogg | Mar 6, 2019 at 8:40 AM EST

Top Analyst Upgrades and Downgrades: CSX, Intelsat, Kohl’s, NIO, Rio Tinto, TripAdvisor, VMware and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included CSX, Intelsat, Kohl's, NIO, Rio Tinto, Teva Pharmaceutical, TripAdvisor…

Chris Lange | Feb 27, 2019 at 4:03 PM EST

Wednesday’s Biggest Winners and Losers in the S&P 500

Wednesday was a flat day for the broad U.S. markets. We saw Best Buy’s report lead retailers today. And as…

Jon C. Ogg | Feb 27, 2019 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: Benefitfocus, Chubb, Dominion, Home Depot, Karyopharm, Mylan, Philip Morris, Weight Watchers and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included Benefitfocus, Chubb, Dominion Energy, Home Depot, Karyopharm Therapeutics, Mylan,…

Jon C. Ogg | Jan 30, 2019 at 4:23 PM EST

Asthma and COPD Patients Score With Generic Advair Diskus FDA Approval

More and more branded drugs seem to be facing generic competition. The impact might not be so positive for Big…

Jon C. Ogg | Jan 23, 2019 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Dell, IBM, International Paper, Merck, Pfizer, Tesla, Teva, Walmart and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included Alphabet, Amazon.com, Dell Technologies, IBM, International Paper, Merck, Pfizer,…

Lee Jackson | Nov 15, 2018 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: Altice, Blue Apron, CubeSmart, Horizon Pharma, KB Home, Las Vegas Sands, Mylan, Switch and More

The top analyst upgrades, downgrades and other research calls from Wednesday included Altice, Blue Apron, CubeSmart, Horizon Pharma, KB Home,…

Chris Lange | Nov 7, 2018 at 1:55 PM EST

The 10 Best Stocks This Earnings Season

Here 24/7 Wall St. has included 10 stocks that saw the best earnings performance so far this season.

Jon C. Ogg | Nov 6, 2018 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, AMAG Pharma, Crocs, HCA, Kellogg, Kosmos Energy, Mylan, Pandora, Square and More

The top analyst upgrades, downgrades and initiations seen on Tuesday included AbbVie, AMAG Pharmaceuticals, Crocs, HCA, Kellogg, Kosmos Energy, Mylan,…

Chris Lange | Nov 6, 2018 at 8:35 AM EST

What Drove Mylan Earnings in Q3

Mylan reported better-than-expected quarterly results late Monday, and shares rose sharply in Friday's premarket.

Chris Lange | Oct 9, 2018 at 10:20 AM EDT

Mylan’s Mapi Collaboration for Multiple Sclerosis Doesn’t Seem to Be Paying Off

Mylan shares hit a 52-week low after Mapi Pharma announced midstage results from its multiple sclerosis trial.

Jon C. Ogg | Oct 9, 2018 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Baker Hughes, Blackbaud, Box, CSX, Intuit, Mylan, Tesla, Vodafone, Walmart and More

The top analyst upgrades, downgrades and initiations seen on Tuesday included Apple, Baker Hughes, Blackbaud, Box, CSX, Intuit, Mylan, Tesla,…

Jon C. Ogg | Oct 5, 2018 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Carbonite, Cleveland-Cliffs, Conoco, Costco, EA, Eli Lilly, HP, PepsiCo, Roku and More

The top analyst upgrades, downgrades and initiations seen on Friday included Carbonite, Cleveland-Cliffs, Conoco, Costco, EA, Eli Lilly, HP, PepsiCo…

1 2 3 4 … 12

Mylan Inc. : MYL

All MYL Articles

What to Expect When Mylan Reports Tuesday

Lyft, GoPro, Disney, Yelp and More Major Earnings Coming This Week

Top Analyst Upgrades and Downgrades: Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan, NextEra, Peabody, Teva, Yum Brands and More

Top Analyst Upgrades and Downgrades: CSX, Intelsat, Kohl’s, NIO, Rio Tinto, TripAdvisor, VMware and More

Wednesday’s Biggest Winners and Losers in the S&P 500

Top Analyst Upgrades and Downgrades: Benefitfocus, Chubb, Dominion, Home Depot, Karyopharm, Mylan, Philip Morris, Weight Watchers and More

Asthma and COPD Patients Score With Generic Advair Diskus FDA Approval

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Dell, IBM, International Paper, Merck, Pfizer, Tesla, Teva, Walmart and More

Top Analyst Upgrades and Downgrades: Altice, Blue Apron, CubeSmart, Horizon Pharma, KB Home, Las Vegas Sands, Mylan, Switch and More

The 10 Best Stocks This Earnings Season

Top Analyst Upgrades and Downgrades: AbbVie, AMAG Pharma, Crocs, HCA, Kellogg, Kosmos Energy, Mylan, Pandora, Square and More

What Drove Mylan Earnings in Q3

Mylan’s Mapi Collaboration for Multiple Sclerosis Doesn’t Seem to Be Paying Off

Top Analyst Upgrades and Downgrades: Apple, Baker Hughes, Blackbaud, Box, CSX, Intuit, Mylan, Tesla, Vodafone, Walmart and More

Top Analyst Upgrades and Downgrades: Carbonite, Cleveland-Cliffs, Conoco, Costco, EA, Eli Lilly, HP, PepsiCo, Roku and More

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

Mylan Inc. : MYL

All MYL Articles

What to Expect When Mylan Reports Tuesday

Lyft, GoPro, Disney, Yelp and More Major Earnings Coming This Week

Top Analyst Upgrades and Downgrades: Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan, NextEra, Peabody, Teva, Yum Brands and More

Top Analyst Upgrades and Downgrades: CSX, Intelsat, Kohl’s, NIO, Rio Tinto, TripAdvisor, VMware and More

Wednesday’s Biggest Winners and Losers in the S&P 500

Top Analyst Upgrades and Downgrades: Benefitfocus, Chubb, Dominion, Home Depot, Karyopharm, Mylan, Philip Morris, Weight Watchers and More

Asthma and COPD Patients Score With Generic Advair Diskus FDA Approval

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Dell, IBM, International Paper, Merck, Pfizer, Tesla, Teva, Walmart and More

Top Analyst Upgrades and Downgrades: Altice, Blue Apron, CubeSmart, Horizon Pharma, KB Home, Las Vegas Sands, Mylan, Switch and More

The 10 Best Stocks This Earnings Season

Top Analyst Upgrades and Downgrades: AbbVie, AMAG Pharma, Crocs, HCA, Kellogg, Kosmos Energy, Mylan, Pandora, Square and More

What Drove Mylan Earnings in Q3

Mylan’s Mapi Collaboration for Multiple Sclerosis Doesn’t Seem to Be Paying Off

Top Analyst Upgrades and Downgrades: Apple, Baker Hughes, Blackbaud, Box, CSX, Intuit, Mylan, Tesla, Vodafone, Walmart and More

Top Analyst Upgrades and Downgrades: Carbonite, Cleveland-Cliffs, Conoco, Costco, EA, Eli Lilly, HP, PepsiCo, Roku and More

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

Featured Reads

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026